Ctrip's talks to buy a major group buying site look like a worrisome diversion from its core online travel services, and also hint of desperation as it looks for M&A targets.
Cheetah's IPO performed respectably thanks to strong support from the company's backers, but its shares will edge lower in the next few weeks as sentiment cools towards Chinese tech firms.
Sina's preliminary quarterly results show it is growing strongly despite a new government crackdown on some non-core units. But the stock could be volatile for the next two months due to momentum selling.
A new clampdown on content from online video sites is likely to have a moderate impact on their business, and is most likely in response to pressure from traditional broadcasters.
A government clampdown on Sina over illicit content on its video and literature sites looks largely symbolic, and it is unlikely to have any longer-term impact on the company.
Youku Tudou's and Huawei's new Internet TV product could stand a strong chance of success, drawing on the strength of its 2 partners as leaders in their respective fields.
A new strategic tie-up between eLong and Tongcheng could foreshadow an eventual merger of the 2 online travel agents, creating a new challenger to industry leaders Ctrip and Qunar.
A combination of Ctrip and Qunar could be coming, with Baidu as the new company's controlling stakeholder, though the deal could get vetoed by China's anti-monopoly regulator.
An upcoming IPO for E-House's Leju unit should perform reasonably well following a significant new investment from leading Internet firm Tencent.
Yingli's latest weak earnings are the result of legacy issues that could be gone by next year, while Renren will need to find a strategic partner to reverse its falling revenues and widening losses.
Twitter CEO Dick Costolo's upcoming visit to China indicates he may be reconsidering the world's largest Internet market despite Beijing's tough censorship requirements.
E-House is likely to move ahead with a plan to separately list its Leju unit and could get a short boost after an IPO, but the stock is likely to stall over the long term.
iKang Healthcare's IPO could enjoy modest success due to its position as a top Chinese clinic operator, but it will have to overcome broader investor indifference to Chinese healthcare stocks.
Dangdang's latest tie-up with Yhd.com shows it has no interest in finding a true strategic partner, setting it up to fail or become marginalized if it tries to remain independent.
Dangdang and Youku Tudou shares could see upside as both swing into the profit column, though neither is likely to remain independent over the long term.
China's advertising dependent Internet companies are likely to see a slow but gradual erosion of their ad revenue growth throughout 2014 as the market slows and competition increases.